Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Wednesday, 15 Apr 2015

Written Answers Nos. 489-502

Health Insurance

Ceisteanna (489)

Maureen O'Sullivan

Ceist:

489. Deputy Maureen O'Sullivan asked the Minister for Health in view of the drive towards private health care currently taking place with the 2% levy for those of 34 years of age and older taking out private cover, his views that further regulation is taking place to ensure that private patients who are alleviating public health waiting lists and outpatient facilities are receiving value for their money; and if he will make a statement on the matter. [14107/15]

Amharc ar fhreagra

Freagraí scríofa

Lifetime Community Rating (LCR) is being introduced to encourage people to take out private health insurance at a younger age. Encouraging more people to join the market at younger ages helps spread the costs of older and less healthy people across the market, helping to support affordable premiums for all.

The introduction of LCR is one of a suite of measures which I announced in November 2014 to address the rising health insurance premiums and stabilise the private health insurance market in the interests of consumers. Other measures introduced include a reduction in stamp duty, a reduction in the Health Insurance Authority levy and the introduction of 'Young Adult' rates of premium from 1 May 2015, based on a sliding scale of maximum chargeable rates up to age 26. Young adult rates will ensure the phasing-in of full adult rates and ease the effect of the dramatic price increase experienced when student rates no longer apply. The package of measures I announced in November also includes key recommendations set out in the two Pat McLoughlin reports on Private Health Insurance costs and builds on Budget 2015 which included a freeze on hospital bed charges and no decrease in the relievable amount for tax relief purposes. Taken together, these measures are intended to help control premium inflation and to create a sustainable market where health insurance is affordable for as many people as possible.

There are a broad range of plans available in the health insurance market, providing varying levels of cover from basic to comprehensive level. This facilitates consumer choice when purchasing health insurance and consumers should actively seek out plans which offer the most suitable level of cover, and which provide the greatest value for money, for their individual needs. I would encourage individuals to carefully review their private health insurance requirements when taking out, or renewing, a health insurance contract. Many customers can make savings on their health insurance premiums by reviewing the level of cover required to meet their needs. The Health Insurance Authority provides information to consumers in this regard and may be contacted at Lo-call 1850 929166 or at www.hia.ie.

Patient Transport

Ceisteanna (490)

Maureen O'Sullivan

Ceist:

490. Deputy Maureen O'Sullivan asked the Minister for Health if he will intervene and ensure that there is a day ambulance service offered for elderly patients, many of whom are old and in receipt of State pensions, and cannot afford a private taxi to attend the day hospital at Saint Mary's Hospital in the Phoenix Park as the service has been suspended due to financial restraints; and if he will make a statement on the matter. [14108/15]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter it has been referred to the Health Service Executive for direct reply. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.

Hospice Services Provision

Ceisteanna (491)

Brian Stanley

Ceist:

491. Deputy Brian Stanley asked the Minister for Health the steps that have been taken to address the differential in funding for hospice care per capita between the midlands region and other regions in the mid-west and the north west. [14115/15]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter it has been referred to the Health Service Executive for direct reply. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.

Hospice Services Provision

Ceisteanna (492)

Brian Stanley

Ceist:

492. Deputy Brian Stanley asked the Minister for Health if he will provide a specialist hospice day care service one day a week in each of the midland hospitals. [14116/15]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter it has been referred to the Health Service Executive for direct reply. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.

Question No. 493 answered with Question No. 485.

Health Services Access

Ceisteanna (494)

Finian McGrath

Ceist:

494. Deputy Finian McGrath asked the Minister for Health the position regarding a place in a health centre in County Kildare in respect of a person (details supplied); and if he will make a statement on the matter. [14138/15]

Amharc ar fhreagra

Freagraí scríofa

As this is a service issue this question has been referred to the HSE for direct reply. If you have not received a reply within 15 working days, please contact my Private Office and they will follow up the matter with them.

Hospital Services

Ceisteanna (495)

Finian McGrath

Ceist:

495. Deputy Finian McGrath asked the Minister for Health if he will address the ambulance and trolley crisis at Beaumont Hospital in Dublin 9; and if he will make a statement on the matter. [14139/15]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter, I have asked the HSE to respond to you directly. If you have not received a reply from the HSE within 15 working days please contact my Private Office and my officials will follow the matter up.

Rights of People with Disabilities

Ceisteanna (496)

Finian McGrath

Ceist:

496. Deputy Finian McGrath asked the Minister for Health if he will support a matter on protecting children and adults with an intellectual disability (details supplied); and the plans in place to protect children and adults with a disability from being sexually assaulted in our care services. [14149/15]

Amharc ar fhreagra

Freagraí scríofa

I would like to thank the Deputy for enclosing the article which is shocking. I understand that the Judge in this case ruled that the individuals and organisations involved were not to be identified in order to protect the victim.

Every person who uses our disability services is entitled to expect and receive supports of the highest standard and to live in an atmosphere of safety and care.

The notification of allegations of any/ all complaints of any abuse, sexual or otherwise, in relation to vulnerable adults by staff working in care centres should be referred to the Health Service Executive (HSE) for investigation under its National Policy and Procedures for Safeguarding Vulnerable Persons at Risk of Abuse.

The safeguarding and protection of vulnerable people in the care of the health service is of paramount importance. The Director General of the HSE has written to all staff instructing them to take personal responsibility for ensuring that individuals supported by the HSE in any setting are treated with dignity and respect.

The HSE has undertaken a number of initiatives to ensure that quality and safe care in services for people with disabilities is appropriately implemented and monitored, including:

- The establishment of a National Implementation Taskforce, including a series of National Summits to improve client safety, dignity, respect and culture;

- Implementation of the National Policy & Procedures on Safeguarding Vulnerable Persons at Risk of Abuse;

- Development of an Advocacy programme;

- Implementation of an evaluation and quality improvement programme in disability residential centres;

- Development of an implementation plan for any recommendations arising from the McCoy review of residential services in Áras Attracta when complete and,

- Development of long term sustainable & evidence-based safeguarding practices and training programmes specific to residential settings.

In addition the HSE has appointed Ms. Leigh Gath as "Confidential Recipient" for the Health Service. The Confidential Recipient is independent in her functions. She has the authority to examine complaints or disclosures of abuse of vulnerable persons in receipt of HSE funded services and has the authority to:

- Independently advise and assist individuals on the best course of action to take to raise matters of concern;

- Assist with the referral and examination of concerns; and

- Ensure these matters are appropriately addressed by the HSE and its funded agencies.

In view of the seriousness of this matter, I have asked the HSE to provide a report to me and I will contact the Deputy once I have received and considered the report.

Medicinal Products Availability

Ceisteanna (497)

David Stanton

Ceist:

497. Deputy David Stanton asked the Minister for Health the number of persons registered for the drug payment scheme; the number of medical card holders respectively who are currently being prescribed Nadolol to treat life-threatening cardiac conditions; the position regarding medical card holders and payment for Nadolol; if his Department or the Health Service Executive plan to review their positions in this regard; and if he will make a statement on the matter. [14152/15]

Amharc ar fhreagra

Freagraí scríofa

There are currently no products authorised in Ireland containing Nadolol, nor are there any applications pending with the Health Products Regulatory Authority for such products.

Nadolol was previously authorised under the brand name Corgard, however, these authorisations were withdrawn by the marketing authorisation holder Sanofi in 2000. The product is however still authorised in some European countries. The Health Products Regulatory Authority has received notification from wholesalers that products containing Nadolol have been imported into Ireland under the notification scheme for exempt medicinal products.

The Health (Pricing and Supply of Medical Goods) Act 2013 sets out the rules and criteria around reimbursement of medicinal products. Under the Act the HSE can only add items to the reimbursement list which have a marketing authorisation.

In exceptional circumstances the Act authorises the HSE to fund reimbursement of items not on the reimbursable list for individual patients provided the patient requires that item for clinical reasons and that there is no listed item which is a suitable alternative for that item in so far as the patient is concerned.

The HSE has confirmed that it has funded Nadolol for individuals when applications are made which provide evidence which allow the HSE to utilise the exceptional criteria provided under the 2013 Act.

As the other issues raised in this question relate to the administration of the GMS and Community Drugs Schemes the question has been referred to the HSE for direct reply on those issues. If you have not received a response within 15 working days, please contact my Private Office and they will follow up the matter with them.

Medicinal Products Availability

Ceisteanna (498)

David Stanton

Ceist:

498. Deputy David Stanton asked the Minister for Health if he is aware of cases where patients with serious cardiac conditions who have been prescribed Nadolol are unable to access the drug due to the high cost or lack of availability; the options available to such patients; and if he will make a statement on the matter. [14153/15]

Amharc ar fhreagra

Freagraí scríofa

There are currently no products authorised in Ireland containing Nadolol, nor are there any applications pending with the Health Products Regulatory Authority for such products.

Nadolol was previously authorised under the brand name Corgard, however, these authorisations were withdrawn by the marketing authorisation holder Sanofi in 2000. The product is however still authorised in some European countries. The Health Products Regulatory Authority has received notification from wholesalers that products containing Nadolol have been imported into Ireland under the notification scheme for exempt medicinal products.

The Health (Pricing and Supply of Medical Goods) Act 2013 sets out the rules and criteria around reimbursement of medicinal products. Under the Act the HSE can only add items to the reimbursement list which have a marketing authorisation.

In exceptional circumstances the Act authorises the HSE to fund reimbursement of items not on the reimbursable list for individual patients provided the patient requires that item for clinical reasons and that there is no listed item which is a suitable alternative for that item in so far as the patient is concerned.

The HSE has confirmed that it has funded Nadolol for individuals when applications are made which provide evidence which allow the HSE to utilise the exceptional criteria provided under the 2013 Act.

Hospital Accommodation Provision

Ceisteanna (499)

Tom Fleming

Ceist:

499. Deputy Tom Fleming asked the Minister for Health the position regarding the availability of convalescence beds and respite beds in the Saint Columbanus Home and Community Hospital in Killarney in County Kerry; the number of beds that are vacant to cope with the demand the many vulnerable patients with flu symptoms; and if he will make a statement on the matter. [14154/15]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter it has been referred to the Health Service Executive for direct reply. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.

Irish Language

Ceisteanna (500)

Terence Flanagan

Ceist:

500. Deputy Terence Flanagan asked the Minister for Health the steps being taken to promote the use of Irish in his Department; and if he will make a statement on the matter. [14175/15]

Amharc ar fhreagra

Freagraí scríofa

My Department is committed to ensuring that customers who wish to conduct their business through Irish can be facilitated to the greatest extent possible. The Department has 7 staff or almost 2 % of the total number of employees who are capable of carrying out their duties through both the Irish and English languages. All written correspondence addressed to the Department in Irish is replied to in Irish and any telephone queries are referred to one of the members of staff competent in Irish.

The Department's Language Scheme 2015-2018 sets out the extent to which the Department’s services are currently available through Irish, and identifies areas for future enhancement such as press and communication services and the Department’s website.

From 2015, Public Appointments Service panels include persons with specific competencies in the Irish language and it is the intention of the Department to fill any gaps identified in our current staffing in this area from such panels. In addition 5 members of staff are currently undertaking a Certificate in Professional Irish course approved by the Department of Arts, Heritage and the Gaeltacht.

Health Services

Ceisteanna (501)

Fergus O'Dowd

Ceist:

501. Deputy Fergus O'Dowd asked the Minister for Health if he will respond to a briefing received from Cystic Fibrosis Ireland; and if he will make a statement on the matter. [14180/15]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter, I have asked the HSE to respond to you directly. If you have not received a reply from the HSE within 15 working days please contact my Private Office and my officials will follow the matter up.

Medicinal Products Availability

Ceisteanna (502, 562)

Pat Breen

Ceist:

502. Deputy Pat Breen asked the Minister for Health further to Parliamentary Question No 479 of 21 January 2015, if he will provide an update on the application lodged with the Health Service Executive for the inclusion of the drug Fampyra for multiple sclerosis under the community drugs scheme; when a decision will issue; and if he will make a statement on the matter. [14202/15]

Amharc ar fhreagra

John O'Mahony

Ceist:

562. Deputy John O'Mahony asked the Minister for Health his plans to make Fampyra available to multiple sclerosis suffers; and if he will make a statement on the matter. [14417/15]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 502 and 562 together.

As was noted in the reply to the question of the 20 January 2015, a revised application was received by the HSE on the 25 July 2014 for the inclusion of Fampridine (Fampyra) on the community drugs schemes. The HSE has since been engaging with the company seeking an improved commercial offering and these engagements have been completed. It is not possible to say when a decision on the funding of this medication will be made as the HSE is considering the outcome of those commercial engagements as well as the outcome of discussions which the HSE has had with clinical experts regarding this drug.

Barr
Roinn